Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (IPNSAE)

Civil Hospices of Lyon

Status: Unknown

Conditions: Paraneoplastic Neurological Syndrome; Autoimmune Encephalitis

Study type: Observational

Funder types: Other

Identifiers

NCT03957616

IPNSAE

Details and patient eligibility

About

This study aims to provide an estimate of the incidence of paraneoplastic neurological syndromes and autoimmune encephalitides in France between the years 2016 and 2018. The study will describe the incidence of antibody subtypes and regional variations.

Enrollment: 600 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of Paraneoplastic Neurological Syndrome (PNS) or Autoimmune Encephalitis (AE) made by the referring physician to the national center for PNS and AE in Lyon between 2016 and 2018

Exclusion criteria

• Data on location of diagnosis missing
• Patients diagnosed out of the mainland French territory
• Patients for whom insufficient data was available

Trial design

600 participants in 1 patient group

Paraneoplastic neurological syndromes patients

Description:

Patients tested for Paraneoplastic neurological syndromes (PNS) and Autoimmune Encephalitis (AE) with a lumbar puncture, with detection of an antibody or negative, but with PNS clinically diagnosed.